IL-6, which was found to be elevated in NMO, was shown to improve PB survival as well as AQP4-Ab secretion; however, blocking IL-6 receptor (IL-6R) signaling using an anti-IL-6R antibody decreased PB survival in vitro. The gene discussed is AQP4; the disease is neuromyelitis optica.